Autres langues uniQure N.V.

Actions

QURE

NL0010696654

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 25/04/2024			Varia. 5j.	Varia. 1 janv.
4,54 ^USD	-0,44 %		-3,61 %	-32,94 %

12/04	Uniqure N.V. annonce que Paula Soteropoulos ne se présentera pas à la réélection en tant qu'administrateur non exécutif	CI
02/04	UNIQURE N.V. : UBS à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Uniqure N.V. Announces Paula Soteropoulos Will Not Stand for Re-Election as Non-Executive Director	12/04
UniQure N.V.(NasdaqGS:QURE) dropped from S&P Biotechnology Select Industry Index	18/03
UniQure N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
UniQure Announces 2023 Financial Results and Highlights Recent Company Progress	28/02
UniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease	19/12
UniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease	19/12
UniQure N.V. Announces Update on Phase I/II Clinical Trials of Amt-130Gene Therapy for the Treatment of Huntington's Disease	19/12
UniQure N : December 2023 Huntington's Disease Program Update AMT-130	19/12
UniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	08/12
UniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	08/12
UniQure Says US FDA Clears Investigational New Drug Application for Fabry Disease Candidate	29/11
UniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease	29/11
UniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease	29/11
UniQure N.V. Announces FDA Clearance of Investigational New Drug Application for Amt-191 Gene Therapy for Fabry Disease	29/11
Worldwide Healthcare Trust net asset value slips in volatile markets	23/11
UniQure N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Earnings Flash (QURE) UNIQURE Posts Q3 Revenue $1.4M	07/11
UniQure: Q3 Earnings Snapshot	07/11
UniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress	07/11
UniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress	07/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues uniQure N.V.

Actions

QURE

NL0010696654

Autres langues

Filtres